Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesvi... (lts could differ materially from those s...)

HOME >> MEDICINE >> NEWS

Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket

Date:3/13/2008

lts could differ materially from those set forth in any forward- looking statements.

Factors that could cause Hill-Rom's actual results to differ from forward- looking statements include but are not limited to: Hill-Rom's dependence on its relationships with several large group purchasing organizations, whether Hill-Rom's new products are successful in the marketplace, changes in customers' Medicare reimbursements, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of Hill-Rom's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in Hill-Rom's business or other adverse consequences resulting from the planned separation of Hillenbrand's two operating companies, failure to realize the anticipated benefits of the separation, failure of Hill-Rom to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax- related matters. For a more in depth discussion of these and other factors that could cause Hill-Rom's actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Hillenbrand's Annual Report on Form 10-K for the period ended September 30, 2007.

Factors that could cause Batesville's actual results to differ from forward-looking statements include but are not limited to: Batesville's dependence on its relationships with several large national providers, changes in death rates, whether Batesville's new products are successful in the marketplace, antitrust litigation, potential exposure to product liability or other
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
2. Hillenbrand Industries Announces Second Quarter 2008 Dividend
3. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
4. Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
5. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
8. Verdict One Releases Directory of Board Certified Attorneys for Consumers
9. Academy releases emergency preparedness tools to enable millions more people to shelter in place
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. MITEM Releases Blue Iris eLaborate 8.6

Post Your Comments:

Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesvi...(lts could differ materially from those s...),Health